|
TRICell Stem Cell Centre, an affiliate of
LifeCell, has been set up in Sri Ramachandra Medical Centre,
Chennai, with state-of-the-art therapeutics facility to provide
clinical applications through stem cell therapy. It was
inaugurated recently by former President, A P J Abdul Kalam.
TRICell will provide comprehensive treatment in the field of
haemato-oncology and is a gateway in bringing evidence-based
therapies in many more clinical applications.
S Abhaya Kumar, vice-chairman, TRICell, said,
"TRICell is being developed in various stages, which would
enable stem cell transplantation for haematological problems and
malignancies and also facilitate stem cell transplantations for
other specific disorders. We are confident that this facility
will offer affordable clinical services to the patients bringing
regenerative therapy to the forefront and prove to be a boon to
the people who are waiting to undergo stem cell treatment at
affordable cost."
V R Venkataachalam, Chancellor, Sri
Ramachandra University (SRU), said, "I am delighted that this is
a combination of an excellent clinical unit with a stem cell
research facility and will open new avenues in patient care,
research and teaching. With this tie-up, we will be providing
the benefits of scientific advancement to the people in India."
"We have invested about Rs 5 croe to begin with in this centre
for research activities to be carried out by world renowned stem
cell therapists and are committed to invest more funds in this
segment. The tie-up with SRU has allowed access for customers of
TRICell to support services such as ICU, analytical and testing
facilities. I am happy that TRICell will be able to introduce
the concept of regenerative medicine and will remain the
clinical platform for all future stem cell-related work and
therapies at affordable costs," Abhaya added.
TRICell will support research and treatment of cancers affecting
the blood - haemato-oncology. At a later stage, TRICell will
introduce treatment methods of regenerative medicine - a concept
in which stem cells are induced to differentiate into the
specific cell types required to repair damaged or destroyed cell
populations. Regenerative medicine will be the clinical platform
for all future stem cell related work. Treatment through bone
marrow, allogeneic peripheral blood stem cell, mini allogeneic,
autologous stem cell and cord blood transplant would be
available at TRICell.
The centre also aims at a holistic approach to open new avenues
in patient care, research and teaching backed by LifeCell and
SRU.
R Rangaraj
|
